Targeting PI3K/Akt/mTOR for the management of psoriasis

靶向 PI3K/Akt/mTOR 治疗银屑病

基本信息

  • 批准号:
    9030172
  • 负责人:
  • 金额:
    $ 33.66万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-09-01 至 2020-07-31
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): The continued objective of this proposal is to determine the critical role of PI3K/Akt/mTOR in psoriasis pathogenesis and to develop delphinidin for the management of psoriasis, a common chronic inflammatory skin disorder that affects 125 million people worldwide. Although psoriasis is not life- threatening, it presents disabling physical and psychosocial discomfort and global disease burden associated with psoriatic arthritis and cardiovascular disease risks. Being multifactorial, it is unlikely that hiting a single target will significantly benefit patients, thus the need for developing effective mechanism and target-based agents to treat psoriasis. Among the many signaling networks implicated in psoriasis disease, the PI3K/AKT/mTOR pathway has emerged as clinically relevant target, as it may cooperatively promote psoriasis. Using retrospective human psoriatic and imiquimod (IMQ)-induced murine psoriasis-like skin lesional tissues we observed activation of AKT/mTOR signaling compared to matched controls. These observations form the basis of our proposal that simultaneous targeting of PI3K/Akt/mTOR may be an effective approach for treating psoriasis. In line with this hypothesis and in our pursuit for non-toxic natural agents endowed with pro- differentiation and anti-inflammatory properties in skin, we recently made some novel and exciting observations with delphinidin. Delphinidin treatment of human keratinocytes pre-stimulated with/without IL-22 inhibited PI3K, Akt and mTOR activation. Further competitive binding and in silico docking analyses revealed that delphindin physically interacts with the PI3K, mTOR and p70S6K kinases with binding energy of -7 to -8.9Kcal/mol range, In this application, we propose to take advantage of the multi-pronged ability of delphinidin and is designed to: 1) Examine the involvement of PI3K/Akt/mTOR and secondary signaling in psoriasis pathogenesis; 2) Investigate the efficacy of delphinidin using (i) in-vitro 2D cultures, i) 3D reconstituted human skin models of psoriasis, and iii) in-vivo IMQ-induced Balbc and TPA-induced K14/VEGF transgenic murine psoriasiform models that recapitulates many features of human psoriasis. A successful completion of this proposal may result in our understanding of mechanism of psoriasis pathogenesis via dissecting interaction of PI3K/AKT/mTOR and the development of delphindin as a novel agent against proliferative keratinizing disorders, including psoriasis.
 描述(由申请人提供):本提案的持续目标是确定PI 3 K/Akt/mTOR在银屑病发病机制中的关键作用,并开发用于治疗银屑病的飞燕草素,银屑病是一种常见的慢性炎症性皮肤病,影响全球1.25亿人。虽然银屑病不危及生命,但它表现出致残的身体和心理社会不适以及与银屑病关节炎和心血管疾病风险相关的全球疾病负担。由于是多因素的,因此不太可能击中单一目标将使患者显著受益,因此需要开发有效的机制 以及治疗银屑病的靶向药物。在参与银屑病疾病的许多信号传导网络中,PI 3 K/AKT/mTOR通路已成为临床相关靶点,因为它可能协同促进银屑病。使用回顾性人类银屑病和咪喹莫特(IMQ)诱导的鼠银屑病样皮肤病变组织,我们观察到与匹配对照相比AKT/mTOR信号转导的激活。这些观察结果构成了我们提出的同时靶向PI 3 K/Akt/mTOR可能是治疗银屑病的有效方法的基础。根据这一假设,并且在我们对在皮肤中赋予促分化和抗炎性质的无毒天然试剂的追求中,我们最近对飞燕草素进行了一些新颖且令人兴奋的观察。用/不用IL-22预刺激的人角质形成细胞的飞燕草苷处理抑制PI 3 K、Akt和mTOR活化。进一步的竞争结合和计算机对接分析显示,飞燕草素与PI 3 K、mTOR和p70 S6 K激酶以-7至-8.9Kcal/mol范围的结合能物理地相互作用。在本申请中,我们提出利用飞燕草素的多管齐下的能力,并且设计用于:1)检查PI 3 K/Akt/mTOR和次级信号在银屑病发病机制中的参与; 2)使用(i)体外2D培养物,i)银屑病的3D重建人皮肤模型,和iii)体内MQ诱导的Balbc和TPA诱导的K14/VEGF转基因鼠银屑病样模型研究飞燕草素的功效,所述模型概括了人银屑病的许多特征。该提案的成功完成可能会导致我们通过剖析PI 3 K/AKT/mTOR的相互作用来理解银屑病发病机制,并开发Delphindin作为对抗增殖性角化疾病(包括银屑病)的新型药物。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Hasan Mukhtar其他文献

Hasan Mukhtar的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Hasan Mukhtar', 18)}}的其他基金

Defining the role of miR-30 in human skin
定义 miR-30 在人类皮肤中的作用
  • 批准号:
    8813976
  • 财政年份:
    2014
  • 资助金额:
    $ 33.66万
  • 项目类别:
Defining the role of miR-30 in human skin
定义 miR-30 在人类皮肤中的作用
  • 批准号:
    8923147
  • 财政年份:
    2014
  • 资助金额:
    $ 33.66万
  • 项目类别:
Developing Fisetin for the Managment of Prostate Cancer
开发非瑟酮治疗前列腺癌
  • 批准号:
    8278499
  • 财政年份:
    2011
  • 资助金额:
    $ 33.66万
  • 项目类别:
Developing Fisetin for the Managment of Prostate Cancer
开发非瑟酮治疗前列腺癌
  • 批准号:
    8160855
  • 财政年份:
    2011
  • 资助金额:
    $ 33.66万
  • 项目类别:
Developing Fisetin for the Managment of Prostate Cancer
开发非瑟酮治疗前列腺癌
  • 批准号:
    8473681
  • 财政年份:
    2011
  • 资助金额:
    $ 33.66万
  • 项目类别:
Developing Fisetin for the Managment of Prostate Cancer
开发非瑟酮治疗前列腺癌
  • 批准号:
    9064262
  • 财政年份:
    2011
  • 资助金额:
    $ 33.66万
  • 项目类别:
Developing Fisetin for the Managment of Prostate Cancer
开发非瑟酮治疗前列腺癌
  • 批准号:
    8644570
  • 财政年份:
    2011
  • 资助金额:
    $ 33.66万
  • 项目类别:
Developing Fisetin for the Managment of Prostate Cancer
开发非瑟酮治疗前列腺癌
  • 批准号:
    8681386
  • 财政年份:
    2011
  • 资助金额:
    $ 33.66万
  • 项目类别:
Targeting PI3K/Akt/mTOR for the management of psoriasis
靶向 PI3K/Akt/mTOR 治疗银屑病
  • 批准号:
    9751767
  • 财政年份:
    2010
  • 资助金额:
    $ 33.66万
  • 项目类别:
Targeting PI3K/Akt/mTOR for the management of psoriasis
靶向 PI3K/Akt/mTOR 治疗银屑病
  • 批准号:
    9144314
  • 财政年份:
    2010
  • 资助金额:
    $ 33.66万
  • 项目类别:

相似海外基金

How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
  • 批准号:
    BB/Z514391/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.66万
  • 项目类别:
    Training Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
  • 批准号:
    2312555
  • 财政年份:
    2024
  • 资助金额:
    $ 33.66万
  • 项目类别:
    Standard Grant
RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
  • 批准号:
    2327346
  • 财政年份:
    2024
  • 资助金额:
    $ 33.66万
  • 项目类别:
    Standard Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
  • 批准号:
    ES/Z502595/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.66万
  • 项目类别:
    Fellowship
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
  • 批准号:
    23K24936
  • 财政年份:
    2024
  • 资助金额:
    $ 33.66万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
  • 批准号:
    ES/Z000149/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.66万
  • 项目类别:
    Research Grant
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
  • 批准号:
    2901648
  • 财政年份:
    2024
  • 资助金额:
    $ 33.66万
  • 项目类别:
    Studentship
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
  • 批准号:
    488039
  • 财政年份:
    2023
  • 资助金额:
    $ 33.66万
  • 项目类别:
    Operating Grants
New Tendencies of French Film Theory: Representation, Body, Affect
法国电影理论新动向:再现、身体、情感
  • 批准号:
    23K00129
  • 财政年份:
    2023
  • 资助金额:
    $ 33.66万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The Protruding Void: Mystical Affect in Samuel Beckett's Prose
突出的虚空:塞缪尔·贝克特散文中的神秘影响
  • 批准号:
    2883985
  • 财政年份:
    2023
  • 资助金额:
    $ 33.66万
  • 项目类别:
    Studentship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了